Share
Share
It should not surprise us that even in parts of the genome where we dont obviously see a functional code (i.e., one thats been evolutionarily fixed as a result of some selective advantage), there is a type of code, but not like anything weve previously considered as such. And what if it were doing something in three dimensions as well as the two dimensions of the ATGC code? A paper just published in BioEssays explores this tantalizing possibility
Isnt it wonderful to have a really perplexing problem to gnaw on, one that generates almost endless potential explanations. How about what is all that non-coding DNA doing in genomes?that 98.5% of human genetic material that doesnt produce proteins. To be fair, the deciphering of non-coding DNA is making great strides via the identification of sequences that are transcribed into RNAs that modulate gene expression, may be passed on transgenerationally (epigenetics) or set the gene expression program of a stem cell or specific tissue cell. Massive amounts of repeat sequences (remnants of ancient retroviruses) have been found in many genomes, and again, these dont code for protein, but at least there are credible models for what theyre doing in evolutionary terms (ranging from genomic parasitism to symbiosis and even exploitation by the very host genome for producing the genetic diversity on which evolution works); incidentally, some non-coding DNA makes RNAs that silence these retroviral sequences, and retroviral ingression into genomes is believed to have been the selective pressure for the evolution of RNA interference (so-called RNAi); repetitive elements of various named types and tandem repeats abound; introns (many of which contain the aforementioned types of non-coding sequences) have transpired to be crucial in gene expression and regulation, most strikingly via alternative splicing of the coding segments that they separate.
Still, theres plenty of problem to gnaw on because although we are increasingly understanding the nature and origin of much of the non-coding genome and are making major inroads into its function (defined here as evolutionarily selected, advantageous effect on the host organism), were far from explaining it all, andmore to the pointwere looking at it with a very low-magnification lens, so to speak. One of the intriguing things about DNA sequences is that a single sequence can encode more than one piece of information depending on what is reading it and in which direction viral genomes are classic examples in which genes read in one direction to produce a given protein overlap with one or more genes read in the opposite direction (i.e., from the complementary strand of DNA) to produce different proteins. Its a bit like making simple messages with reverse-pair words (a so-called emordnilap). For example: REEDSTOPSFLOW, which, by an imaginary reading device, could be divided into REED STOPS FLOW. Read backwards, it would give WOLF SPOTS DEER.
Now, if it is of evolutionary advantage for two messages to be coded so economically as is the case in viral genomes, which tend to evolve towards minimum complexity in terms of information content, hence reducing necessary resources for reproductionthen the messages themselves evolve with a high degree of constraint. What does this mean? Well, we could word our original example message as RUSH-STEM IMPEDES CURRENT, which would embody the same essential information as REED STOPS FLOW. However, that message, if read in reverse (or even in the same sense, but in different chunks) does not encode anything additional that is particularly meaningful. Probably the only way of conveying both pieces of information in the original messages simultaneously is the very wording REEDSTOPSFLOW: thats a highly constrained system! Indeed, if we studied enough examples of reverse-pair phrases in English, we would see that they are, on the whole, made up of rather short words, and the sequences are missing certain units of language such as articles (the, a); if we looked more closely, we might even detect a greater representation than average of certain letters of the alphabet in such messages. We would see these as biases in word and letter usage that would, a priori, allow us to have a stab at identifying such dual-function pieces of information.
Now lets return to the letters, words, and information encoded in genomes. For two distinct pieces of information to be encoded in the same piece of genetic sequence we would, similarly, expect the constraints to be manifest in biases of word and letter usagethe analogies, respectively, for amino acid sequences constituting proteins, and their three-letter code. Hence a sequence of DNA can code for a protein and, in addition, for something else. This something else, according to Giorgio Bernardi, is information that directs the packaging of the enormous length of DNA in a cell into the relatively tiny nucleus. Primarily it is the code that guides the binding of the DNA-packaging proteins known as histones. Bernardi refers to this as the genomic codea structural code that defines the shape and compaction of DNA into the highly-condensed form known as chromatin.
But didnt we start with an explanation for non-coding DNA, not protein-coding sequences? Yes, and in the long stretches of non-coding DNA we see information in excess of mere repeats, tandem repeats and remnants of ancient retroviruses: there is a type of code at the level of preference for the GC pair of chemical DNA bases compared with AT. As Bernardi reviews, synthesizing his and others groundbreaking work, in the core sequences of the eukaryotic genome, the GC content in structural organizational units of the genome termed isochores increased during the evolutionary transition between so-called cold-blooded and warm-blooded organisms. And, fascinatingly, this sequence bias overlaps with sequences that are much more constrained in function: these are the very protein-coding sequences mentioned earlier, and theymore than the intervening non-coding sequencesare the clue to the genomic code.
Protein-coding sequences are also packed and condensed in the nucleus particularly when theyre not in use (i.e., being transcribed, and then translated into protein) but they also contain relatively constant information on precise amino acid identities, otherwise they would fail to encode proteins correctly: evolution would act on such mutations in a highly negative manner, making them extremely unlikely to persist and be visible to us. But the amino acid code in DNA has a little catch that evolved in the most simple of unicellular organisms (bacteria and archaea) billions of years ago: the code is partly redundant. For example, the amino acid Threonine can be coded in eukaryotic DNA in no fewer than four ways: ACT, ACC, ACA or ACG. The third letter is variable and hence available for the coding of extra information. This is exactly what happens to produce the genomic code, in this case creating a bias for the ACC and ACG forms in warm-blooded organisms. Hence, the high constraint on this additional codewhich is also seen in parts of the genome that are not under such constraint as protein-coding sequencesis imposed by the packaging of protein-coding sequences that embody two sets of information simultaneously. This is analogous to our example of the highly-constrained dual-information sequence REEDSTOPSFLOW.
Importantly, however, the constraint is not as strict as in our English language example because of the redundancy of the third position of the triplet code for amino acids: a better analogy would be SHE*ATE*STU* where the asterisk stands for a variable letter that doesnt make any difference to the machine that reads the three-letter component of the four-letter message. One could then imagine a second level of information formed by adding D at these asterisk points, to make SHEDATEDSTUD (SHE DATED STUD). Next imagine a second reading machine that looks for meaningful phrases of a sensitive nature containing a greater than average concentration of Ds. This reading machine carries a folding machine with it that places a kind of peg at each D, kinking the message by 120 degrees in a plane. a point where the message should be bent by 120 degrees in the same plane, we would end up with a more compact, triangular, version. In eukaryotic genomes, the GC sequence bias proposed to be responsible for structural condensation extends into non-coding sequences, some of which have identified activities, though less constrained in sequence than protein-coding DNA. There it directs their condensation via histone-containing nucleosomes to form chromatin.
Figure. Analogy between condensation of a word-based message and condensation of genomic DNA in the cell nucleus. Panel A: Information within information, a sequence of words with a variable fourth space which, when filled with particular letters, generates a further message. One message is read by a three-letter reading machine; the other by a reading machine that can interpret information extending to the 4thvariableposition of the sequence. The second reader recognizes sensitive information that should be concealed, and at the points where a D appears in the 4th position, it folds the string of words, hence compressing the sensitive part and taking it out of view. This is an analogy for the principle of genomic 3D compression via chromatin, as depicted in panel B: a fluorescence image (via Fluorescence In-Situ Hybridization FISH) of the cell nucleus. H2/H3 isochores, which increased in GC content during evolution from cold-blooded to warm-blooded vertebrates, are compressed into a chromatin core, leaving L1 isochores (with lower GC content) at the periphery in a less-condensed state. The genomic code embodied in the high-GC tracts of the genome is, according to Bernardi [1], read by the nucleosome-positioning machinery of the cell and interpreted as sequence to be highly compressed in euchromatin. Acknowledgements: Panel A: concept and figure production: Andrew Moore; Panel B: A FISH pattern of H2/H3 and L1 isochores from a lymphocyte induced by PHAcourtesy of S. Sacconeas reproduced in Ref. [1].]
These regions of DNA may then be regarded as structurally important elements in forming the correct shape and separation of condensed coding sequences in the genome, regardless of any other possible function that those non-coding sequences have: in essence, this would be an explanation for the persistence in genomes of sequences to which no function (in terms of evolutionarily-selected activity), can be ascribed (or, at least, no substantial function).
A final analogythis time much more closely relatedmight be the very amino acid sequences in large proteins, which do a variety of twists, turns, folds etc. We may marvel at such complicated structures and ask but do they need to be quite so complicated for their function? Well, maybe they do in order to condense and position parts of the protein in the exact orientation and place that generates the three-dimensional structure that has been successfully selected by evolution. But with a knowledge that the genomic code overlaps protein coding sequences, we might even start to become suspicious that there is another selective pressure at work as well
Andrew Moore, Ph.D.Editor-in-Chief, BioEssays
Reference:
1. G.Bernardi. 2019. The genomic code: a pervasive encoding/moulding ofchromatin structures and a solution of the non-coding DNA mystery. BioEssays41:12. 1900106
Here is the original post:
That Junk DNA Is Full of Information! - Advanced Science News
- 001 Strange lesions after stem-cell therapy [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 002 Pat McCrory will do the right thing. He supports non-embryonic stem cell research. - Video [Last Updated On: October 13th, 2011] [Originally Added On: October 13th, 2011]
- 003 The potential of stem cells.flv - Video [Last Updated On: October 15th, 2011] [Originally Added On: October 15th, 2011]
- 004 StemEnhance is the Biggest Scientific Medical breakthrough of our time - World Exclusive! - Video [Last Updated On: October 16th, 2011] [Originally Added On: October 16th, 2011]
- 005 Hiv Positive Man Cured - Video [Last Updated On: October 16th, 2011] [Originally Added On: October 16th, 2011]
- 006 Invitrx "Reluma" with Habib Torfi - Video [Last Updated On: October 17th, 2011] [Originally Added On: October 17th, 2011]
- 007 Negative Campaign against Bonnie Marge Westerford - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 008 HIV Resistant Genes...Rhesus Negative, Excess PK [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 009 Insidermedicine in 60 - December 7, 2007 - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 010 Stem Cell Therapy - BioLogic Anti-Aging Skin Cream - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 011 Stem Cell Research (Government Hilbrands) - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 012 Stem Cell News ISCO.MP4 - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 013 N5-FG-108-all_30fps.AVI - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 014 Stem cell [Last Updated On: October 21st, 2011] [Originally Added On: October 21st, 2011]
- 015 Steam Cell Reasearch - Video [Last Updated On: October 24th, 2011] [Originally Added On: October 24th, 2011]
- 016 Meat from a petri dish may be on the menu soon :oP - Video [Last Updated On: October 26th, 2011] [Originally Added On: October 26th, 2011]
- 017 Mmmm meat from a petri dish may be on the menu soon - Video [Last Updated On: October 26th, 2011] [Originally Added On: October 26th, 2011]
- 018 Parents of a CP Girl - Talk about Stem Cell Treatment Experience (2) - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- 019 George Somlo, MD - What is triple negative breast cancer? | City of Hope - Video [Last Updated On: October 28th, 2011] [Originally Added On: October 28th, 2011]
- 020 Stem Enhance - Stem Cell Enhancer - Video [Last Updated On: October 28th, 2011] [Originally Added On: October 28th, 2011]
- 021 VistaGen's Cardiac OrganDots(TM) Produced for Drug Rescue - Video [Last Updated On: November 10th, 2011] [Originally Added On: November 10th, 2011]
- 022 The Power of Stem Cells - Video [Last Updated On: November 10th, 2011] [Originally Added On: November 10th, 2011]
- 023 Adult stem cell treatment, quality and testing - Video [Last Updated On: November 26th, 2011] [Originally Added On: November 26th, 2011]
- 024 Cord Blood Stem Cell Transfusion Saves 3-Year-Old Child - Video [Last Updated On: December 7th, 2011] [Originally Added On: December 7th, 2011]
- 025 Dr. Uma Lakshimipathy presents Generation of Transgene-Free Induced Pluripotent Stem Cells - Video [Last Updated On: December 28th, 2011] [Originally Added On: December 28th, 2011]
- 026 StemFlo - Blood Circulation Enhancer, Antioxidant and More!.flv - Video [Last Updated On: January 1st, 2012] [Originally Added On: January 1st, 2012]
- 027 Dr Tony Talebi discusses treatment of multiple myeloma patients with Dr Ratzan - Video [Last Updated On: January 2nd, 2012] [Originally Added On: January 2nd, 2012]
- 028 Dr Tony Talebi discusses stem cell transplantation in Myeloma with Dr Ratzan - Video [Last Updated On: January 2nd, 2012] [Originally Added On: January 2nd, 2012]
- 029 Frank Young Joins Bioheart as Financial Consultant [Last Updated On: January 31st, 2012] [Originally Added On: January 31st, 2012]
- 030 Scientists use old theory to discover new targets in fight against breast cancer [Last Updated On: February 13th, 2012] [Originally Added On: February 13th, 2012]
- 031 Salk Scientists Use an Old Theory to Discover New Targets in the Fight Against Breast Cancer [Last Updated On: February 13th, 2012] [Originally Added On: February 13th, 2012]
- 032 Life Technologies Scientist Uma Lakshmipathy presents, "Solving Challenges in the Generation of Induced Pluripotent ... [Last Updated On: February 15th, 2012] [Originally Added On: February 15th, 2012]
- 033 Bioheart to Present at BioFlorida's Saturday Exchange [Last Updated On: February 15th, 2012] [Originally Added On: February 15th, 2012]
- 034 Nasal Stem Cells Show Promise in Repairing Spinal Cord Damage Caused by Contusion [Last Updated On: February 22nd, 2012] [Originally Added On: February 22nd, 2012]
- 035 Gentium Responds to the EMA's Day 120 List of Questions for Defibrotide MAA [Last Updated On: February 22nd, 2012] [Originally Added On: February 22nd, 2012]
- 036 Bone Marrow Prolotherapy at Caring Medical - Dr. Ross Hauser - Video [Last Updated On: February 23rd, 2012] [Originally Added On: February 23rd, 2012]
- 037 Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call [Last Updated On: February 25th, 2012] [Originally Added On: February 25th, 2012]
- 038 Mass. General researchers isolate egg-producing stem cells from adult human ovaries [Last Updated On: February 27th, 2012] [Originally Added On: February 27th, 2012]
- 039 The Lancet Publishes Results from Gentium's Phase III Defibrotide Trial for the Prevention of VOD in Paediatric Patients [Last Updated On: February 28th, 2012] [Originally Added On: February 28th, 2012]
- 040 Egg-producing stem cells isolated from adult human ovaries [Last Updated On: February 28th, 2012] [Originally Added On: February 28th, 2012]
- 041 This is the only time bad breath is a good thing [Last Updated On: March 1st, 2012] [Originally Added On: March 1st, 2012]
- 042 BGI Demos Single-Cell Exome Sequencing Method on Tumor Cell Lines, Patient Samples [Last Updated On: March 7th, 2012] [Originally Added On: March 7th, 2012]
- 043 Cancer Paradigm Shift: Biomarker Links Clinical Outcome with New Model of Lethal Tumor Metabolism [Last Updated On: March 15th, 2012] [Originally Added On: March 15th, 2012]
- 044 NCCN Presents New Guidelines for Acute Lymphoblastic Leukemia [Last Updated On: March 21st, 2012] [Originally Added On: March 21st, 2012]
- 045 Bioheart Labs and Stemlogix Veterinary Products Featured in Media [Last Updated On: March 23rd, 2012] [Originally Added On: March 23rd, 2012]
- 046 ImmunoCellular Therapeutics to Present on Cancer Stem Cell Targeting at the AACR Annual Meeting [Last Updated On: March 27th, 2012] [Originally Added On: March 27th, 2012]
- 047 Are Cancer Stem Cells Ready for Prime Time? [Last Updated On: April 1st, 2012] [Originally Added On: April 1st, 2012]
- 048 Bacterin International Holdings, Inc. Schedules First Quarter 2012 Financial Earnings Conference Call [Last Updated On: April 25th, 2012] [Originally Added On: April 25th, 2012]
- 049 Apple to the Rescue [Last Updated On: April 25th, 2012] [Originally Added On: April 25th, 2012]
- 050 Bacterin Secures Accounts Receivable Credit Facility [Last Updated On: April 25th, 2012] [Originally Added On: April 25th, 2012]
- 051 Gentium Receives Day 180 List of Outstanding Issues From the CHMP for Defibrotide MAA [Last Updated On: May 4th, 2012] [Originally Added On: May 4th, 2012]
- 052 Stem cell shield may protect body from chemotherapy side effects [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 053 Gene-modified stem cell transplant protects patients from toxic side effects of chemotherapy [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 054 Gene-modified stem cell transplant protects patients from toxic side effects of chemotherapy, study suggests [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 055 Stem cell jab cuts chemo side effects [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 056 Boston scientists grow lung tissue from cystic fibrosis patients’ skin cells [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 057 New England Journal of Medicine Reports on Three Phase III REVLIMID® (lenalidomide) Trials in Patients with Newly ... [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 058 Transplanted Gene-Modified Blood Stem Cells Protect Brain Cancer Patients From Toxic Side Effects of Chemotherapy [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 059 Stem cells jab 'helps brain cancer patients tolerate chemotherapy' [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 060 'Cell shield' for cancer patients [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- 061 Researchers find a way to delay aging of stem cells [Last Updated On: May 25th, 2012] [Originally Added On: May 25th, 2012]
- 062 Method to delay aging of stem cells developed [Last Updated On: May 25th, 2012] [Originally Added On: May 25th, 2012]
- 063 Verastem to Present Scientific Data at the 2012 ASCO Annual Meeting [Last Updated On: May 29th, 2012] [Originally Added On: May 29th, 2012]
- 064 Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved [Last Updated On: May 31st, 2012] [Originally Added On: May 31st, 2012]
- 065 Breast stem cell research: Receptor teamwork required and a new pathway may be involved [Last Updated On: May 31st, 2012] [Originally Added On: May 31st, 2012]
- 066 This Week in Pathology [Last Updated On: June 1st, 2012] [Originally Added On: June 1st, 2012]
- 067 China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 [Last Updated On: June 12th, 2012] [Originally Added On: June 12th, 2012]
- 068 Cryo-Save Group N.V: Further cost savings with closure of France [Last Updated On: June 14th, 2012] [Originally Added On: June 14th, 2012]
- 069 Cell Therapeutics Appoints New Chief Medical Officer [Last Updated On: June 14th, 2012] [Originally Added On: June 14th, 2012]
- 070 Gentium Submits Day 180 Response to List of Outstanding Issues Received From the EMA's CHMP for Defibrotide MAA [Last Updated On: June 21st, 2012] [Originally Added On: June 21st, 2012]
- 071 Bioheart's Chief Science Officer Kristin Comella Presents at 10th Annual Meeting of International Society for Stem ... [Last Updated On: June 25th, 2012] [Originally Added On: June 25th, 2012]
- 072 Bioheart Announces New Brand Image, Launches Redesigned Website and New Company Logo [Last Updated On: June 27th, 2012] [Originally Added On: June 27th, 2012]
- 073 Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of ... [Last Updated On: July 4th, 2012] [Originally Added On: July 4th, 2012]
- 074 Scientists Find New Way to Up Safety Factor of Stem Cell Therapy by Causing Contaminated Cells to Purge Themselves [Last Updated On: October 1st, 2012] [Originally Added On: October 1st, 2012]
- 075 Arlen Specter praised as fighter from a more moderate era [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- 076 Nanodiamond coating for a better Petri dish [Last Updated On: October 16th, 2012] [Originally Added On: October 16th, 2012]
- 077 Bioheart Extends Licenses of Electrical Stimulation Patents With Airspeed [Last Updated On: October 18th, 2012] [Originally Added On: October 18th, 2012]
- 078 Stem Cells Therapy [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 079 Stem Cell Research - Stem Cell Treatments - Treatments ... [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 080 5. Hematopoietic Stem Cells [Stem Cell Information] [Last Updated On: May 24th, 2015] [Originally Added On: May 24th, 2015]